Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 08 Sept 2023 for Surface Oncology, Inc..
Filing timeline
BuySaleRobert W. Ross
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert W. Ross: trading record in brief
Robert W. Ross, listed as chief executive, appears in our data through filings on Surface Oncology, Inc. shares, published by SEC (Form 4). Between 4 January 2019 and 8 September 2023, the trades on record add up to 14 filings.
Every open-market trade on record is a sale: 10 sales worth €363k. Other entries cover 2 share grants and 1 option exercise. Since January 2023: no purchases and 1 sale on the market.
The newest entry dates from 8 September 2023: a transaction, in Surface Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert W. Ross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
83,193 sharesCommon StockSEC:0001209191-23-048757:0
16,713 shares@ US$0.943.8% of flowCommon StockSEC:0001209191-23-045494:0
10,594 shares@ US$1.724.7% of flowCommon StockSEC:0001209191-22-044673:0
56,000 shares0Common StockSEC:0001209191-22-015966:0
33,500 shares@ US$6.1084.3% of flowCommon StockSEC:0001209191-22-003397:0
5 of 5 declarations
